Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-08-30

AUTHORS

M Oosterveld, P Muus, S Suciu, C Koller, G Verhoef, B Labar, P Wijermans, C Aul, D Fière, D Selleslag, R Willemze, A Gratwohl, A Ferrant, F Mandelli, J Cortes, T de Witte, E Estey

ABSTRACT

Comparisons of the effectiveness of chemotherapy and transplantation in AML in first complete remission (CR) have focused almost exclusively on patients with de novo disease. Here we used Cox modelling to compare these strategies in patients with MDS and s-AML treated by the Leukemia Group of the EORTC or at the MD Anderson Cancer Center. All patients were aged 15–60. The 184 EORTC patients received conventional dose ara-C + idarubicin + etoposide for remission induction, and after one consolidation course, were scheduled to receive an allograft, or an autograft if a sibling donor was unavailable. The 215 MDA patients received various high-dose ara-C containing induction regimens, and in CR, continued to receive these regimens at reduced dose for 6–12 months. CR rates were 54% EORTC and 63% MDA (P = 0.09). Sixty-five of the 100 EORTC patients who entered CR received a transplant in first CR. Disease-free survival in patients achieving CR was superior in the EORTC cohort, the 4-years DFS rates were 28.9% (s.e. = 4.8%) EORTC vs 17.3% (s.e. = 3.7%) MDA (P = 0.017). Survival from CR was not significantly different in the EORTC and MDA groups, as was survival from start of treatment. After accounting for prognostic factors the conclusions were unchanged. Despite various problems with the analysis discussed below, the data suggest that neither transplantation nor chemotherapy, as currently practised, can be unequivocally recommended for these patients in first CR and that questions as to the superior modality may be less important than the need to improve results with both. More... »

PAGES

1615-1621

References to SciGraph publications

  • 1991. Modelling Binary Data in NONE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.leu.2402591

    DOI

    http://dx.doi.org/10.1038/sj.leu.2402591

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1022507850

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/12200672


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Acute Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Age Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Blood Cell Count", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytogenetic Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease-Free Survival", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukemia, Myeloid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myelodysplastic Syndromes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Odds Ratio", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Remission Induction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Risk Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transplantation, Homologous", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University Medical Centre Nijmegen, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.10417.33", 
              "name": [
                "University Medical Centre Nijmegen, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Oosterveld", 
            "givenName": "M", 
            "id": "sg:person.0770464173.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770464173.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University Medical Centre Nijmegen, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.10417.33", 
              "name": [
                "University Medical Centre Nijmegen, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Muus", 
            "givenName": "P", 
            "id": "sg:person.01054761151.73", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054761151.73"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "EORTC Data Center, Brussels, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.418936.1", 
              "name": [
                "EORTC Data Center, Brussels, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Suciu", 
            "givenName": "S", 
            "id": "sg:person.01014211567.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014211567.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "MD Anderson Cancer Center, Houston, Texas, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "MD Anderson Cancer Center, Houston, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Koller", 
            "givenName": "C", 
            "id": "sg:person.01244616761.64", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244616761.64"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University Hospital Gasthuisberg, Leuven, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410569.f", 
              "name": [
                "University Hospital Gasthuisberg, Leuven, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Verhoef", 
            "givenName": "G", 
            "id": "sg:person.01115543643.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115543643.61"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Clinical Hospital Rebro, Zagreb, Croatia", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Clinical Hospital Rebro, Zagreb, Croatia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Labar", 
            "givenName": "B", 
            "id": "sg:person.01104727454.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104727454.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Leijenburg Hospital, The Hague, The Netherlands", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Leijenburg Hospital, The Hague, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wijermans", 
            "givenName": "P", 
            "id": "sg:person.010061377417.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Heinrich Heine University, Dusseldorf, Germany", 
              "id": "http://www.grid.ac/institutes/grid.411327.2", 
              "name": [
                "Heinrich Heine University, Dusseldorf, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Aul", 
            "givenName": "C", 
            "id": "sg:person.01300444115.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300444115.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "H\u00f4pital Edouard Herriot, Lyon, France", 
              "id": "http://www.grid.ac/institutes/grid.412180.e", 
              "name": [
                "H\u00f4pital Edouard Herriot, Lyon, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fi\u00e8re", 
            "givenName": "D", 
            "id": "sg:person.01347772711.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347772711.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "St Jan's Hospital, Brugge, Belgium", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "St Jan's Hospital, Brugge, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Selleslag", 
            "givenName": "D", 
            "id": "sg:person.07711475767.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07711475767.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Leiden University Medical Centre, Leiden, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.10419.3d", 
              "name": [
                "Leiden University Medical Centre, Leiden, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Willemze", 
            "givenName": "R", 
            "id": "sg:person.016652044162.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016652044162.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Kantonsspital, Basel, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.410567.1", 
              "name": [
                "Kantonsspital, Basel, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gratwohl", 
            "givenName": "A", 
            "id": "sg:person.01021337771.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021337771.37"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cliniques Universitaires St Luc, Brussels, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.48769.34", 
              "name": [
                "Cliniques Universitaires St Luc, Brussels, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ferrant", 
            "givenName": "A", 
            "id": "sg:person.0731140104.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731140104.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University La Sapienza, Roma, Italy", 
              "id": "http://www.grid.ac/institutes/grid.7841.a", 
              "name": [
                "University La Sapienza, Roma, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mandelli", 
            "givenName": "F", 
            "id": "sg:person.01156336023.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156336023.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "MD Anderson Cancer Center, Houston, Texas, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "MD Anderson Cancer Center, Houston, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cortes", 
            "givenName": "J", 
            "id": "sg:person.016160407152.27", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016160407152.27"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University Medical Centre Nijmegen, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.10417.33", 
              "name": [
                "University Medical Centre Nijmegen, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "de Witte", 
            "givenName": "T", 
            "id": "sg:person.015730551677.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015730551677.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "MD Anderson Cancer Center, Houston, Texas, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "MD Anderson Cancer Center, Houston, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Estey", 
            "givenName": "E", 
            "id": "sg:person.014332430327.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014332430327.24"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-1-4899-4475-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1108488400", 
              "https://doi.org/10.1007/978-1-4899-4475-7"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2002-08-30", 
        "datePublishedReg": "2002-08-30", 
        "description": "Comparisons of the effectiveness of chemotherapy and transplantation in AML in first complete remission (CR) have focused almost exclusively on patients with de novo disease. Here we used Cox modelling to compare these strategies in patients with MDS and s-AML treated by the Leukemia Group of the EORTC or at the MD Anderson Cancer Center. All patients were aged 15\u201360. The 184 EORTC patients received conventional dose ara-C + idarubicin + etoposide for remission induction, and after one consolidation course, were scheduled to receive an allograft, or an autograft if a sibling donor was unavailable. The 215 MDA patients received various high-dose ara-C containing induction regimens, and in CR, continued to receive these regimens at reduced dose for 6\u201312 months. CR rates were 54% EORTC and 63% MDA (P = 0.09). Sixty-five of the 100 EORTC patients who entered CR received a transplant in first CR. Disease-free survival in patients achieving CR was superior in the EORTC cohort, the 4-years DFS rates were 28.9% (s.e. = 4.8%) EORTC vs 17.3% (s.e. = 3.7%) MDA (P = 0.017). Survival from CR was not significantly different in the EORTC and MDA groups, as was survival from start of treatment. After accounting for prognostic factors the conclusions were unchanged. Despite various problems with the analysis discussed below, the data suggest that neither transplantation nor chemotherapy, as currently practised, can be unequivocally recommended for these patients in first CR and that questions as to the superior modality may be less important than the need to improve results with both.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.leu.2402591", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1097065", 
            "issn": [
              "0887-6924", 
              "1476-5551"
            ], 
            "name": "Leukemia", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "9", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "16"
          }
        ], 
        "keywords": [
          "first complete remission", 
          "complete remission", 
          "prognostic factors", 
          "high-risk myelodysplastic syndrome", 
          "secondary acute myeloid leukemia", 
          "MD Anderson Cancer Center", 
          "conventional-dose ara", 
          "de novo disease", 
          "risk myelodysplastic syndromes", 
          "disease-free survival", 
          "high-dose Ara", 
          "start of treatment", 
          "effectiveness of chemotherapy", 
          "acute myeloid leukemia", 
          "Anderson Cancer Center", 
          "s-AML", 
          "DFS rates", 
          "novo disease", 
          "remission induction", 
          "consolidation courses", 
          "Cox modelling", 
          "leukemia group", 
          "dose ara", 
          "CR rate", 
          "myelodysplastic syndrome", 
          "Cancer Center", 
          "MDA patients", 
          "myeloid leukemia", 
          "MDA group", 
          "patients", 
          "EORTC", 
          "chemotherapy", 
          "superior modality", 
          "transplantation", 
          "survival", 
          "parallel study", 
          "MDA", 
          "ara", 
          "induction", 
          "remission", 
          "regimens", 
          "allografts", 
          "group", 
          "idarubicin", 
          "transplant", 
          "syndrome", 
          "autograft", 
          "AML", 
          "cohort", 
          "leukemia", 
          "etoposide", 
          "disease", 
          "dose", 
          "months", 
          "treatment", 
          "factors", 
          "modalities", 
          "rate", 
          "MDS", 
          "conclusion", 
          "donors", 
          "course", 
          "center", 
          "start", 
          "study", 
          "need", 
          "data", 
          "strategies", 
          "effectiveness", 
          "comparison", 
          "analysis", 
          "results", 
          "questions", 
          "problem", 
          "modelling"
        ], 
        "name": "Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors", 
        "pagination": "1615-1621", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1022507850"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.leu.2402591"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "12200672"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.leu.2402591", 
          "https://app.dimensions.ai/details/publication/pub.1022507850"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_358.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.leu.2402591"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402591'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402591'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402591'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2402591'


     

    This table displays all metadata directly associated to this object as RDF triples.

    366 TRIPLES      21 PREDICATES      121 URIs      112 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.leu.2402591 schema:about N02e4957dae914113a0ab311cbecafae0
    2 N050b707401374a72a8e9d4cf50c029e2
    3 N072e7902fa824b1a908aa5c403085449
    4 N1765cff848854ca6b1e5f4e2f25da756
    5 N1b3103c3e8a2480b84d90fd38d966f87
    6 N2a17b2b979b54c6bb153c160ae33c525
    7 N3c6e157068544d87ad2ff69af5e21b79
    8 N3e4b15db7b544cedac73c528128a130b
    9 N527a3319078a4ad98125336d2faf0e15
    10 N6a08388b068f40fb82d6fdabe7ffb18e
    11 N8a0e4665e559498eac82839775860727
    12 N93fa01f8e41942a9912150049602b06c
    13 N9db49e1d4e74480e8a3e52f728225afc
    14 Nab8f10d55d0d43e08a654069b323d6b1
    15 Nafdeff04c3e1467ba8a5e5dbc390dac4
    16 Nbc309346a6cb41efa162d25b9bb03eb6
    17 Nbd5bdf30421c4e49a4cab1404f91ae93
    18 Ne019703021bd4b94bc99e0d4175d5405
    19 Neb6c963bb9324e088cf9fa887bd87356
    20 Necf365d59d2741669e3d09cf2cdf8b54
    21 anzsrc-for:11
    22 anzsrc-for:1112
    23 schema:author N13d1f64be3124f4f8de3a671488176e1
    24 schema:citation sg:pub.10.1007/978-1-4899-4475-7
    25 schema:datePublished 2002-08-30
    26 schema:datePublishedReg 2002-08-30
    27 schema:description Comparisons of the effectiveness of chemotherapy and transplantation in AML in first complete remission (CR) have focused almost exclusively on patients with de novo disease. Here we used Cox modelling to compare these strategies in patients with MDS and s-AML treated by the Leukemia Group of the EORTC or at the MD Anderson Cancer Center. All patients were aged 15–60. The 184 EORTC patients received conventional dose ara-C + idarubicin + etoposide for remission induction, and after one consolidation course, were scheduled to receive an allograft, or an autograft if a sibling donor was unavailable. The 215 MDA patients received various high-dose ara-C containing induction regimens, and in CR, continued to receive these regimens at reduced dose for 6–12 months. CR rates were 54% EORTC and 63% MDA (P = 0.09). Sixty-five of the 100 EORTC patients who entered CR received a transplant in first CR. Disease-free survival in patients achieving CR was superior in the EORTC cohort, the 4-years DFS rates were 28.9% (s.e. = 4.8%) EORTC vs 17.3% (s.e. = 3.7%) MDA (P = 0.017). Survival from CR was not significantly different in the EORTC and MDA groups, as was survival from start of treatment. After accounting for prognostic factors the conclusions were unchanged. Despite various problems with the analysis discussed below, the data suggest that neither transplantation nor chemotherapy, as currently practised, can be unequivocally recommended for these patients in first CR and that questions as to the superior modality may be less important than the need to improve results with both.
    28 schema:genre article
    29 schema:isAccessibleForFree false
    30 schema:isPartOf N1bffe23f457b47b9ad22d9ab72332a25
    31 Ndacb689c9002408b98ee84d9c0c8a3d2
    32 sg:journal.1097065
    33 schema:keywords AML
    34 Anderson Cancer Center
    35 CR rate
    36 Cancer Center
    37 Cox modelling
    38 DFS rates
    39 EORTC
    40 MD Anderson Cancer Center
    41 MDA
    42 MDA group
    43 MDA patients
    44 MDS
    45 acute myeloid leukemia
    46 allografts
    47 analysis
    48 ara
    49 autograft
    50 center
    51 chemotherapy
    52 cohort
    53 comparison
    54 complete remission
    55 conclusion
    56 consolidation courses
    57 conventional-dose ara
    58 course
    59 data
    60 de novo disease
    61 disease
    62 disease-free survival
    63 donors
    64 dose
    65 dose ara
    66 effectiveness
    67 effectiveness of chemotherapy
    68 etoposide
    69 factors
    70 first complete remission
    71 group
    72 high-dose Ara
    73 high-risk myelodysplastic syndrome
    74 idarubicin
    75 induction
    76 leukemia
    77 leukemia group
    78 modalities
    79 modelling
    80 months
    81 myelodysplastic syndrome
    82 myeloid leukemia
    83 need
    84 novo disease
    85 parallel study
    86 patients
    87 problem
    88 prognostic factors
    89 questions
    90 rate
    91 regimens
    92 remission
    93 remission induction
    94 results
    95 risk myelodysplastic syndromes
    96 s-AML
    97 secondary acute myeloid leukemia
    98 start
    99 start of treatment
    100 strategies
    101 study
    102 superior modality
    103 survival
    104 syndrome
    105 transplant
    106 transplantation
    107 treatment
    108 schema:name Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
    109 schema:pagination 1615-1621
    110 schema:productId N957c51da4e4340b697323b73e79d541d
    111 Na6788011d13449e6a463b6e898277ae1
    112 Nd1262280531f41d487c37616ee50f3a8
    113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022507850
    114 https://doi.org/10.1038/sj.leu.2402591
    115 schema:sdDatePublished 2022-12-01T06:23
    116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    117 schema:sdPublisher N03d3db13e9c348f8bdcdab2ef1ee9c08
    118 schema:url https://doi.org/10.1038/sj.leu.2402591
    119 sgo:license sg:explorer/license/
    120 sgo:sdDataset articles
    121 rdf:type schema:ScholarlyArticle
    122 N02e4957dae914113a0ab311cbecafae0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Blood Cell Count
    124 rdf:type schema:DefinedTerm
    125 N03d3db13e9c348f8bdcdab2ef1ee9c08 schema:name Springer Nature - SN SciGraph project
    126 rdf:type schema:Organization
    127 N050b707401374a72a8e9d4cf50c029e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Odds Ratio
    129 rdf:type schema:DefinedTerm
    130 N072e7902fa824b1a908aa5c403085449 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Adult
    132 rdf:type schema:DefinedTerm
    133 N13d1f64be3124f4f8de3a671488176e1 rdf:first sg:person.0770464173.00
    134 rdf:rest N60004bd4bd7e4a0eb8e386dad6419db6
    135 N1765cff848854ca6b1e5f4e2f25da756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Risk Factors
    137 rdf:type schema:DefinedTerm
    138 N1b3103c3e8a2480b84d90fd38d966f87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Combined Modality Therapy
    140 rdf:type schema:DefinedTerm
    141 N1bffe23f457b47b9ad22d9ab72332a25 schema:issueNumber 9
    142 rdf:type schema:PublicationIssue
    143 N2a17b2b979b54c6bb153c160ae33c525 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Adolescent
    145 rdf:type schema:DefinedTerm
    146 N2c720c703c03401583171e725b02b9aa rdf:first sg:person.01156336023.18
    147 rdf:rest N5cfb7193f16047e7829ce518907419ef
    148 N329f04dad3354214bc5dc4c160cac7e8 rdf:first sg:person.016652044162.13
    149 rdf:rest N66ae65ea04ca42b8ab1a5e4734bb7429
    150 N3c6e157068544d87ad2ff69af5e21b79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Myelodysplastic Syndromes
    152 rdf:type schema:DefinedTerm
    153 N3e4b15db7b544cedac73c528128a130b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Biomarkers, Tumor
    155 rdf:type schema:DefinedTerm
    156 N40cc1bf8e32b41bdb8563838ccfb1050 rdf:first sg:person.014332430327.24
    157 rdf:rest rdf:nil
    158 N4727cb84e93641209d5335fd161e706b rdf:first sg:person.01104727454.92
    159 rdf:rest N80f9fbb00d9945fdb5f42268910c5701
    160 N527a3319078a4ad98125336d2faf0e15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Cytogenetic Analysis
    162 rdf:type schema:DefinedTerm
    163 N5cfb7193f16047e7829ce518907419ef rdf:first sg:person.016160407152.27
    164 rdf:rest Nf5574dbdd7154adf9ba6e679cde230c8
    165 N60004bd4bd7e4a0eb8e386dad6419db6 rdf:first sg:person.01054761151.73
    166 rdf:rest Nc1dc98d125e640df9d511bce0928255f
    167 N66ae65ea04ca42b8ab1a5e4734bb7429 rdf:first sg:person.01021337771.37
    168 rdf:rest N693a80352ed141ca9864dcf4e193823d
    169 N693a80352ed141ca9864dcf4e193823d rdf:first sg:person.0731140104.16
    170 rdf:rest N2c720c703c03401583171e725b02b9aa
    171 N6a08388b068f40fb82d6fdabe7ffb18e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Disease-Free Survival
    173 rdf:type schema:DefinedTerm
    174 N723406ee027943548b3c706fb64664e4 rdf:first sg:person.01115543643.61
    175 rdf:rest N4727cb84e93641209d5335fd161e706b
    176 N7f0b6e86b1ef4d79a150d6f7a7049691 rdf:first sg:person.01244616761.64
    177 rdf:rest N723406ee027943548b3c706fb64664e4
    178 N80f9fbb00d9945fdb5f42268910c5701 rdf:first sg:person.010061377417.22
    179 rdf:rest Nf162e9a7c7cd410f889a338272ee6329
    180 N84ce77be5a544e978b9e45bd9a05f359 rdf:first sg:person.01347772711.82
    181 rdf:rest N9a8b263cde4b463ea1fb517f66a3c477
    182 N8a0e4665e559498eac82839775860727 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Middle Aged
    184 rdf:type schema:DefinedTerm
    185 N93fa01f8e41942a9912150049602b06c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Leukemia, Myeloid
    187 rdf:type schema:DefinedTerm
    188 N957c51da4e4340b697323b73e79d541d schema:name dimensions_id
    189 schema:value pub.1022507850
    190 rdf:type schema:PropertyValue
    191 N9a8b263cde4b463ea1fb517f66a3c477 rdf:first sg:person.07711475767.54
    192 rdf:rest N329f04dad3354214bc5dc4c160cac7e8
    193 N9db49e1d4e74480e8a3e52f728225afc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Transplantation, Homologous
    195 rdf:type schema:DefinedTerm
    196 Na6788011d13449e6a463b6e898277ae1 schema:name pubmed_id
    197 schema:value 12200672
    198 rdf:type schema:PropertyValue
    199 Nab8f10d55d0d43e08a654069b323d6b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    200 schema:name Prognosis
    201 rdf:type schema:DefinedTerm
    202 Nafdeff04c3e1467ba8a5e5dbc390dac4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name Humans
    204 rdf:type schema:DefinedTerm
    205 Nbc309346a6cb41efa162d25b9bb03eb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    206 schema:name Antineoplastic Combined Chemotherapy Protocols
    207 rdf:type schema:DefinedTerm
    208 Nbd5bdf30421c4e49a4cab1404f91ae93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    209 schema:name Acute Disease
    210 rdf:type schema:DefinedTerm
    211 Nc1dc98d125e640df9d511bce0928255f rdf:first sg:person.01014211567.13
    212 rdf:rest N7f0b6e86b1ef4d79a150d6f7a7049691
    213 Nd1262280531f41d487c37616ee50f3a8 schema:name doi
    214 schema:value 10.1038/sj.leu.2402591
    215 rdf:type schema:PropertyValue
    216 Ndacb689c9002408b98ee84d9c0c8a3d2 schema:volumeNumber 16
    217 rdf:type schema:PublicationVolume
    218 Ne019703021bd4b94bc99e0d4175d5405 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Hematopoietic Stem Cell Transplantation
    220 rdf:type schema:DefinedTerm
    221 Neb6c963bb9324e088cf9fa887bd87356 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name Remission Induction
    223 rdf:type schema:DefinedTerm
    224 Necf365d59d2741669e3d09cf2cdf8b54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Age Factors
    226 rdf:type schema:DefinedTerm
    227 Nf162e9a7c7cd410f889a338272ee6329 rdf:first sg:person.01300444115.40
    228 rdf:rest N84ce77be5a544e978b9e45bd9a05f359
    229 Nf5574dbdd7154adf9ba6e679cde230c8 rdf:first sg:person.015730551677.08
    230 rdf:rest N40cc1bf8e32b41bdb8563838ccfb1050
    231 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    232 schema:name Medical and Health Sciences
    233 rdf:type schema:DefinedTerm
    234 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    235 schema:name Oncology and Carcinogenesis
    236 rdf:type schema:DefinedTerm
    237 sg:journal.1097065 schema:issn 0887-6924
    238 1476-5551
    239 schema:name Leukemia
    240 schema:publisher Springer Nature
    241 rdf:type schema:Periodical
    242 sg:person.010061377417.22 schema:affiliation grid-institutes:None
    243 schema:familyName Wijermans
    244 schema:givenName P
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010061377417.22
    246 rdf:type schema:Person
    247 sg:person.01014211567.13 schema:affiliation grid-institutes:grid.418936.1
    248 schema:familyName Suciu
    249 schema:givenName S
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014211567.13
    251 rdf:type schema:Person
    252 sg:person.01021337771.37 schema:affiliation grid-institutes:grid.410567.1
    253 schema:familyName Gratwohl
    254 schema:givenName A
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021337771.37
    256 rdf:type schema:Person
    257 sg:person.01054761151.73 schema:affiliation grid-institutes:grid.10417.33
    258 schema:familyName Muus
    259 schema:givenName P
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054761151.73
    261 rdf:type schema:Person
    262 sg:person.01104727454.92 schema:affiliation grid-institutes:None
    263 schema:familyName Labar
    264 schema:givenName B
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104727454.92
    266 rdf:type schema:Person
    267 sg:person.01115543643.61 schema:affiliation grid-institutes:grid.410569.f
    268 schema:familyName Verhoef
    269 schema:givenName G
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115543643.61
    271 rdf:type schema:Person
    272 sg:person.01156336023.18 schema:affiliation grid-institutes:grid.7841.a
    273 schema:familyName Mandelli
    274 schema:givenName F
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156336023.18
    276 rdf:type schema:Person
    277 sg:person.01244616761.64 schema:affiliation grid-institutes:grid.240145.6
    278 schema:familyName Koller
    279 schema:givenName C
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244616761.64
    281 rdf:type schema:Person
    282 sg:person.01300444115.40 schema:affiliation grid-institutes:grid.411327.2
    283 schema:familyName Aul
    284 schema:givenName C
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300444115.40
    286 rdf:type schema:Person
    287 sg:person.01347772711.82 schema:affiliation grid-institutes:grid.412180.e
    288 schema:familyName Fière
    289 schema:givenName D
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347772711.82
    291 rdf:type schema:Person
    292 sg:person.014332430327.24 schema:affiliation grid-institutes:grid.240145.6
    293 schema:familyName Estey
    294 schema:givenName E
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014332430327.24
    296 rdf:type schema:Person
    297 sg:person.015730551677.08 schema:affiliation grid-institutes:grid.10417.33
    298 schema:familyName de Witte
    299 schema:givenName T
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015730551677.08
    301 rdf:type schema:Person
    302 sg:person.016160407152.27 schema:affiliation grid-institutes:grid.240145.6
    303 schema:familyName Cortes
    304 schema:givenName J
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016160407152.27
    306 rdf:type schema:Person
    307 sg:person.016652044162.13 schema:affiliation grid-institutes:grid.10419.3d
    308 schema:familyName Willemze
    309 schema:givenName R
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016652044162.13
    311 rdf:type schema:Person
    312 sg:person.0731140104.16 schema:affiliation grid-institutes:grid.48769.34
    313 schema:familyName Ferrant
    314 schema:givenName A
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731140104.16
    316 rdf:type schema:Person
    317 sg:person.0770464173.00 schema:affiliation grid-institutes:grid.10417.33
    318 schema:familyName Oosterveld
    319 schema:givenName M
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770464173.00
    321 rdf:type schema:Person
    322 sg:person.07711475767.54 schema:affiliation grid-institutes:None
    323 schema:familyName Selleslag
    324 schema:givenName D
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07711475767.54
    326 rdf:type schema:Person
    327 sg:pub.10.1007/978-1-4899-4475-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1108488400
    328 https://doi.org/10.1007/978-1-4899-4475-7
    329 rdf:type schema:CreativeWork
    330 grid-institutes:None schema:alternateName Clinical Hospital Rebro, Zagreb, Croatia
    331 Leijenburg Hospital, The Hague, The Netherlands
    332 St Jan's Hospital, Brugge, Belgium
    333 schema:name Clinical Hospital Rebro, Zagreb, Croatia
    334 Leijenburg Hospital, The Hague, The Netherlands
    335 St Jan's Hospital, Brugge, Belgium
    336 rdf:type schema:Organization
    337 grid-institutes:grid.10417.33 schema:alternateName University Medical Centre Nijmegen, The Netherlands
    338 schema:name University Medical Centre Nijmegen, The Netherlands
    339 rdf:type schema:Organization
    340 grid-institutes:grid.10419.3d schema:alternateName Leiden University Medical Centre, Leiden, The Netherlands
    341 schema:name Leiden University Medical Centre, Leiden, The Netherlands
    342 rdf:type schema:Organization
    343 grid-institutes:grid.240145.6 schema:alternateName MD Anderson Cancer Center, Houston, Texas, USA
    344 schema:name MD Anderson Cancer Center, Houston, Texas, USA
    345 rdf:type schema:Organization
    346 grid-institutes:grid.410567.1 schema:alternateName Kantonsspital, Basel, Switzerland
    347 schema:name Kantonsspital, Basel, Switzerland
    348 rdf:type schema:Organization
    349 grid-institutes:grid.410569.f schema:alternateName University Hospital Gasthuisberg, Leuven, Belgium
    350 schema:name University Hospital Gasthuisberg, Leuven, Belgium
    351 rdf:type schema:Organization
    352 grid-institutes:grid.411327.2 schema:alternateName Heinrich Heine University, Dusseldorf, Germany
    353 schema:name Heinrich Heine University, Dusseldorf, Germany
    354 rdf:type schema:Organization
    355 grid-institutes:grid.412180.e schema:alternateName Hôpital Edouard Herriot, Lyon, France
    356 schema:name Hôpital Edouard Herriot, Lyon, France
    357 rdf:type schema:Organization
    358 grid-institutes:grid.418936.1 schema:alternateName EORTC Data Center, Brussels, Belgium
    359 schema:name EORTC Data Center, Brussels, Belgium
    360 rdf:type schema:Organization
    361 grid-institutes:grid.48769.34 schema:alternateName Cliniques Universitaires St Luc, Brussels, Belgium
    362 schema:name Cliniques Universitaires St Luc, Brussels, Belgium
    363 rdf:type schema:Organization
    364 grid-institutes:grid.7841.a schema:alternateName University La Sapienza, Roma, Italy
    365 schema:name University La Sapienza, Roma, Italy
    366 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...